R. Ravasio, S. Antonelli, V. Rogai, W. Fakhouri, J. P. Capron, and S. Losi, “Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy”, Grhta, vol. 5, no. 1, Jul. 2018.